Rexahn Pharmaceuticals IncAdd to My Watchlist

RNN:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 1.05
    Last
  • 0.01  0.96%
    Today's Change
  • 1.04
    Previous Close
  • Today
     
    0.30
    1.85
    52 Week Low - High
8:04 pm ET 4/24/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding177 million
Market Cap$185 million
Return on Equity ttm-93.71%
Last DividendRNN:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.069
EPS: Year Est. 12/14 ttm-0.075
 
EPS: Quarterly Actual 12/13 -0.02
EPS: Quarterly Est. 3/14 -0.02
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-16.67
Company Description
Rexahn Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops signal inhibitor therapies for cancer, and treatments for central nervous system diseases.
Revenue$0
Net Income$-9 million
Total Assets$15 million
Employees14
Web Sitewww.rexahn.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!